Us Portable Apomorphine Delivery Device Market Size By Applications, By Type, By End-User, By Deployment & By Technology 2032
Portable Apomorphine Delivery Device Market was valued at USD 0.32 Billion in 2022 and is projected to reach USD 0.62 Billion by 2030, growing at a CAGR of 9.1% from 2024 to 2030.
The U.S. portable apomorphine delivery device market is experiencing significant growth, driven by advancements in Parkinson's disease treatment and increasing patient demand for convenient, effective therapies. Apomorphine, a potent dopamine agonist, is utilized to manage motor fluctuations in Parkinson's disease patients, particularly during "off" episodes when traditional medications are less effective. In February 2025, Supernus Pharmaceuticals received approval from the U.S. Food and Drug Administration (FDA) for Onapgo™, a drug-device combination designed to deliver apomorphine continuously under the skin. This innovative device offers a more convenient alternative to current injection methods, which require administration every two hours. Clinical studies have demonstrated that Onapgo™ significantly reduces "off" episodes, enhancing patient quality of life. citeturn0news8 The portable apomorphine delivery device market was valued at approximately USD 350 million in 2022, with projections indicating a robust growth trajectory. The market is anticipated to expand at a compound annual growth rate (CAGR) of 7.5% from 2023 to 2030, reaching an estimated USD 720 million by 2030. citeturn0search3 Key factors contributing to this market expansion include: - **Increasing Prevalence of Parkinson's Disease:** The aging global population is particularly susceptible to neurodegenerative diseases, with Parkinson's being one of the most common. - **Advancements in Drug Delivery Technology:** Innovations in medical devices have led to the development of more efficient and user-friendly delivery systems. - **Heightened Awareness of Apomorphine Therapy Benefits:** Growing recognition of the efficacy of apomorphine in managing motor symptoms has led to increased adoption among healthcare providers and patients. The market is characterized by the presence of several prominent manufacturers, including Evolan Pharma AB (PharmSwed), Supernus Pharmaceuticals, Ever Pharma, and Britannia Pharmaceuticals STADA. These companies are actively engaged in research and development to enhance device functionality and patient compliance. citeturn0search4 In summary, the U.S. portable apomorphine delivery device market is poised for substantial growth, driven by technological advancements, an aging population, and a heightened focus on patient-centric treatment solutions. The approval of devices like Onapgo™ underscores the industry's commitment to improving the management of Parkinson's disease and enhancing patient outcomes.
Get an In-Depth Research Analysis of the Global Portable Apomorphine Delivery Device Market Size And Forecast [2025-2032]
Â
Evolan Pharma AB (PharmSwed)
Supernus Pharmaceuticals
Ever Pharma
Britannia Pharmaceuticals STADA
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Portable Apomorphine Delivery Device Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Portable Apomorphine Delivery Device Market
Pen-type Deliveries
Inhaler-type Devices
Pressurized Metered Dose Inhalers (pMDIs)
Smart Delivery Devices
Disposable Devices
Intranasal Administration
Subcutaneous Administration
Intravenous Administration
Transdermal Administration
Oral Delivery Systems
Hospitals and Clinics
Home Healthcare Settings
Long-term Care Facilities
Ambulatory Surgical Centers
Research and Academic Institutions
Adults
Pediatric Patients
Geriatric Patients
Patients with Chronic Conditions
Patients under Palliative Care
Online Pharmacies
Retail Pharmacies
Direct Manufacturer Sales
Specialty Pharmacies
Hospital Pharmacies
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Portable Apomorphine Delivery Device Market Research Analysis
1. Introduction of the Global Portable Apomorphine Delivery Device Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Portable Apomorphine Delivery Device Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Portable Apomorphine Delivery Device Market, By Type
6. Global Portable Apomorphine Delivery Device Market, By Application
7. Global Portable Apomorphine Delivery Device Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Portable Apomorphine Delivery Device Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/